Skip to main content
OpenTrials

Clinical trial condition

Respiratory Hypersensitivity

Explore clinical trials studying Respiratory Hypersensitivity. Study availability and eligibility vary by location and protocol.

4,455 public trials 324 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Hypersensitivity trial results

Completed

Study to Evaluate the Efficacy and Safety of "Allergovac Poliplus" in Polysensitized Patients With Allergic Rhinitis/Rhinoconjunctivitis, With or Without Asthma

NCT03821077

Conditions
Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +9 more
Locations
  • Centre Assistencial Baix Llobregat Cornellà de Llobregat, Barcelona, Spain
  • Hospital de Igualada Igualada, Barcelona, Spain
  • GAME Centre Medic Sant Boi de Llobregat, Barcelona, Spain
  • Fundación Hospital Calahorra Calahorra, La Rioja, Spain
View Trial Details
Completed

A Bronchoprovocation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CSJ117 in Adult Subjects With Mild Atopic Asthma

NCT03138811

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Novartis Investigative Site Calgary, Alberta, Canada
  • Novartis Investigative Site Edmonton, Alberta, Canada
  • Novartis Investigative Site Hamilton, Ontario, Canada
  • Novartis Investigative Site Québec, Quebec, Canada
View Trial Details
Completed

Study to Assess the Efficacy and Safety of CJM112 in Patients With Inadequately Controlled Severe Asthma

NCT03299686

Conditions
Asthma, Bronchial Diseases, Dyspnea, +11 more
Locations
  • Novartis Investigative Site Fullerton, California, United States
  • Novartis Investigative Site Riverside, California, United States
  • Novartis Investigative Site Denver, Colorado, United States
  • Novartis Investigative Site Boston, Massachusetts, United States
View all 29 locations
View Trial Details
Completed

Study to Compare QVM149 and Free Triple Combination of Salmeterol/Fluticasone + Tiotropium

NCT03158311

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Novartis Investigative Site Berazategui, Buenos Aires, Argentina
  • Novartis Investigative Site CABA, Buenos Aires, Argentina
  • Novartis Investigative Site Caba, Buenos Aires, Argentina
  • Novartis Investigative Site CABA, Buenos Aires, Argentina
View all 163 locations
View Trial Details
Completed

Assess Bronchodilator Effect and Safety of Two Doses of QVM149 Compared to a Fixed Dose Combination of Salmeterol/Fluticasone in Patients With Asthma.

NCT03063086

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Novartis Investigative Site Sofia, Bulgaria
  • Novartis Investigative Site Changchun, Jilin, China
  • Novartis Investigative Site Tianjin, Tianjin Municipality, China
  • Novartis Investigative Site Shanghai, China
View Trial Details
Completed

MAPS & ITEC Cohorts: 6-8 Years Follow-up

NCT03763630

Conditions
Allergy and Immunology, Asthma, Bronchial Diseases, +8 more
Locations
  • University Hospital Southampton NHS Foundation Trust Southampton, Hampshire, United Kingdom
  • David Hyde Asthma and Allergy Centre Newport, Isle of White, United Kingdom
View Trial Details

Related conditions